Oncology & Cancer

Deadliest cancers may respond to new drug treatment strategy

UC San Francisco researchers have found a way to knock down cancers caused by a tumor-driving protein called "myc," paving the way for patients with myc-driven cancers to enroll in clinical trials for experimental treatments.

Alzheimer's disease & dementia

Possible pathway to new therapy for Alzheimer's disease

Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer's disease (AD).

page 4 from 5